Nonclinical services
Ended Awarded Last action
- Contract number
- 75N93022F00008
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $20,439
Award facts
- Contract value 100% obligated
- $20,439.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$15,168 | |
| Original award | $35,607 |
About this award
Sri International, a non-profit research and development organization headquartered in Menlo Park, California, was awarded a delivery order valued at $20,439 by the National Institute of Allergy and Infectious Diseases (NIAID) for nonclinical services. The contract, issued on August 18, 2022, is structured as a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. This award represents a de-obligation modification under the FY 2026 Unclaimed Delivery Order Initiative, which was designed to recapture excess funds. The work will be performed at Sri International's Menlo Park, California facility. No small business set-aside was applied to this contract.
This delivery order is issued under the parent contract titled "Nonclinical Services for Development of Interventional Agents," which is an indefinite delivery vehicle that provides NIAID with flexible access to Sri International's specialized technical capabilities in safety evaluation and toxicology studies. Sri International's extensive experience supporting federal agencies in biomedical sciences and research services positions the organization to deliver the nonclinical testing and evaluation services required by NIAID. The relatively modest contract value reflects the specific scope of this particular delivery order within the broader master agreement framework.
Quick answers
Who was awarded contract 75N93022F00008?
75N93022F00008 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 18, 2022.
How much is contract 75N93022F00008 worth?
The government has obligated $20,439 on 75N93022F00008.
Is contract 75N93022F00008 an order under another contract?
Yes. 75N93022F00008 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93022F00008 competed?
The extent of competition for 75N93022F00008 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award